Uganda’s estimated 100,000 people living with AIDS, who are in urgent need of anti-retrovirals (ARVs) but cannot afford them could soon have access to locally produced ARVs at a cost of less than 50 US cents per day, according to a Ugandan company planning to produce the drugs.